Molnupiravir 200mgCapsule
Antiviral

Molnupiravir 200mg

Molnupiravir

Oral nucleoside analog prodrug that introduces copying errors into SARS-CoV-2 RNA via lethal mutagenesis. Manufactured by Dr. Reddy's and Cipla for COVID-19 treatment export.

Strengths

200mg

Packing

40 capsules/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Molnupiravir 200mg
Dosage Form
Capsule
Available Strengths
200mg
Packing
40 capsules/bottle
Route of Administration
Oral, with or without food
Dosage
800mg (four 200mg capsules) every 12 hours for 5 days; start within 5 days of symptom onset
Indications
Treatment of mild-to-moderate COVID-19 in adults at risk of progression to severe disease
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 25°C
Shelf Life
24 months
Side Effects
Diarrhea, nausea, dizziness, headache
Precautions
Not for use in pregnancy (mutagenicity concern); not for patients who can receive alternate treatments; start within 5 days of symptoms; not for pre/post-exposure prophylaxis

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Molnupiravir 200mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote